Food companies fear obesity drugs as GLP-1 demand rises, industry adapts

A growing number of people are taking GLP-1 obesity drugs, prompting food companies to worry about a lasting decline in demand for their products, according to Reuters. The food industry is trying to address the trend by introducing special product ranges aimed at consumers using these medications.